Ryan J Sullivan Selected Research

Ryan J Sullivan Research Topics

Disease

106	Melanoma (Melanoma, Malignant) 11/2022 - 05/2009
84	Neoplasms (Cancer) 11/2022 - 05/2009
13	Neoplasm Metastasis (Metastasis) 04/2022 - 10/2013
13	Disease Progression 11/2021 - 11/2012
12	Brain Neoplasms (Brain Tumor) 01/2022 - 05/2015
8	Myocarditis (Carditis) 01/2021 - 01/2018
6	Cardiogenic Shock 01/2021 - 01/2016
6	Colitis 01/2020 - 01/2016
5	Heart Block 01/2021 - 01/2018
4	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 12/2019
4	Inflammation (Inflammations) 01/2021 - 11/2019
4	Uveal melanoma 01/2021 - 10/2013
4	Heart Arrest (Cardiac Arrest) 01/2021 - 01/2018
4	Kaposi Sarcoma (Kaposi's Sarcoma) 12/2010 - 06/2008
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 09/2016
3	Fever (Fevers) 01/2022 - 07/2008
3	Meningeal Carcinomatosis 10/2021 - 01/2020
3	COVID-19 01/2021 - 01/2020
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 01/2018
2	Anaplastic Thyroid Carcinoma 04/2022 - 01/2018
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 11/2020
2	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2022 - 10/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2021 - 07/2021
2	Histiocytic Sarcoma 10/2021 - 01/2020
2	Wounds and Injuries (Trauma) 07/2021 - 07/2008
2	Exanthema (Rash) 01/2021 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2019
2	Hypophysitis 09/2019 - 01/2018
2	Infections 12/2010 - 01/2009
2	Carcinogenesis 09/2009 - 04/2007
1	Colorectal Neoplasms (Colorectal Cancer) 04/2022
1	Chills 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Adenocarcinoma 12/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021

Drug/Important Bio-Agent (IBA)

57	Immune Checkpoint InhibitorsIBA 11/2022 - 03/2013
18	IpilimumabIBA 10/2021 - 11/2012
17	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 03/2013
12	trametinibIBA 01/2022 - 03/2013
12	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2014
11	Pharmaceutical PreparationsIBA 11/2022 - 12/2010
11	pembrolizumabIBA 06/2022 - 10/2013
11	dabrafenibIBA 04/2022 - 03/2013
10	AntibodiesIBA 01/2022 - 10/2013
9	Proteins (Proteins, Gene)FDA Link 11/2021 - 10/2013
9	Interleukin-2 (IL2)IBA 06/2021 - 01/2012
8	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2022 - 07/2008
8	LigandsIBA 01/2021 - 03/2013
8	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2012
7	Phosphotransferases (Kinase)IBA 04/2022 - 01/2014
7	AntigensIBA 01/2022 - 03/2013
7	NivolumabIBA 10/2021 - 10/2013
6	VemurafenibIBA 01/2019 - 03/2013
5	CytokinesIBA 04/2022 - 04/2010
5	Monoclonal AntibodiesIBA 11/2021 - 06/2008
5	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2018
5	SteroidsIBA 01/2021 - 01/2018
3	binimetinibIBA 06/2022 - 05/2020
3	encorafenibIBA 06/2022 - 05/2020
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2022 - 10/2013
3	VaccinesIBA 04/2022 - 01/2018
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2021
3	GlucocorticoidsIBA 11/2021 - 01/2018
3	CTLA-4 AntigenIBA 02/2019 - 01/2017
2	CohesinsIBA 01/2022 - 01/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 12/2020
2	AntioxidantsIBA 01/2021 - 09/2009
2	Cell-Free Nucleic AcidsIBA 01/2021 - 11/2014
2	Small Interfering RNA (siRNA)IBA 11/2020 - 12/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2020 - 07/2008
2	Oxidoreductases (Dehydrogenase)IBA 01/2018 - 10/2007
2	ulixertinibIBA 01/2018 - 01/2018
2	Tyrosine Kinase InhibitorsIBA 09/2016 - 05/2015
1	2- (5- (3- chlorophenyl)- 6- (4- chlorophenyl)- 1- (1- (isopropylsulfonyl)- 3- methylbutan- 2- yl)- 3- methyl- 2- oxopiperidin- 3- yl)acetic acidIBA 10/2022
1	AlbuminsIBA 04/2022
1	Peptides (Polypeptides)IBA 04/2022
1	gamma Subunit Interferon-Stimulated Gene Factor 3 (Interferon Stimulated Gene Factor 3, gamma Subunit)IBA 01/2022
1	InterferonsIBA 01/2022
1	Ad26COVS1IBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	EnzymesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Histones (Histone)IBA 01/2022
1	cabozantinibIBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Vaccine AdjuvantsIBA 12/2021
1	Toll-Like Receptor 9IBA 12/2021
1	Angiopoietin-2IBA 11/2021
1	tremelimumabIBA 11/2021
1	MEDI3617IBA 11/2021

Therapy/Procedure

89	Therapeutics 11/2022 - 01/2009
33	Immunotherapy 06/2022 - 03/2013
5	Radiotherapy 07/2021 - 08/2015
4	Drug Therapy (Chemotherapy) 01/2021 - 08/2015
3	Aftercare (After-Treatment) 01/2020 - 01/2016
3	Molecular Targeted Therapy 10/2013 - 05/2009
1	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2022